Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 10 2021
Historique:
received: 10 08 2021
revised: 28 09 2021
accepted: 08 10 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 29 10 2021
Statut: epublish

Résumé

The northern Italian region of Lombardy has been severely affected by the COVID-19 pandemic since its arrival in Europe. However, there are only a few published studies of the possible influence of social and cultural factors on its prevalence in the general population. This cross-sectional study of the San Siro social-housing neighbourhood of Milan, which was carried about between 23 December 2020 and 19 February 2021, found that the prevalence of anti-SARS-CoV-2 nucleocapsid antibodies in the population as a whole was 12.4% (253/2044 inhabitants), but there was a more than two-fold difference between non-Italians and Italians (23.3% vs. 9.1%). Multivariable analyses showed that being more than 50 years old, living in crowded accommodation, being a non-Italian, and having a low educational level were associated with higher odds of a positive SARS-CoV-2 test, whereas a higher level of education, retirement, and being a former or current cigarette smoker were inversely associated with SARS-CoV-2 infection. Our findings are in line with previous observations indicating that a lower socio-economic status may be a risk factor for COVID-19 and show that non-Italians are disproportionately affected by SARS-CoV-2 infection. This suggests that public health policies should focus more on disadvantaged populations.

Identifiants

pubmed: 34682369
pii: ijerph182010621
doi: 10.3390/ijerph182010621
pmc: PMC8535198
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CISOM, ARMANI OLIMPIA MILANO, ASST FBF-SACCO, UNIMI, POLIMI, TECHNOGENETICS
ID : Na

Références

Addiction. 2021 Jun;116(6):1319-1368
pubmed: 33007104
JAMA Intern Med. 2021 Feb 1;181(2):229-236
pubmed: 33165560
Am J Prev Med. 2020 Sep;59(3):326-332
pubmed: 32703702
BMC Infect Dis. 2012 Apr 20;12:95
pubmed: 22520624
Blood Transfus. 2021 May;19(3):181-189
pubmed: 33539289
Euro Surveill. 2020 Jun;25(24):
pubmed: 32583766
BMC Med. 2020 Jul 1;18(1):206
pubmed: 32605617
JAMA. 2020 Jun 2;323(21):2192-2195
pubmed: 32347898
Eur J Intern Med. 2021 Apr;86:41-47
pubmed: 33579579
Public Health. 2020 Jun;183:110-111
pubmed: 32502699
Scand J Public Health. 2021 Feb;49(1):48-56
pubmed: 33406993
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Lancet Glob Health. 2021 Feb;9(2):e110-e111
pubmed: 33197394
J Infect. 2020 Dec;81(6):e10-e12
pubmed: 32961253
Eur J Public Health. 2020 Aug 1;30(4):617-618
pubmed: 32638998
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Lancet Healthy Longev. 2020 Nov;1(2):e80-e88
pubmed: 33521770
Int J Epidemiol. 2021 Jul 9;50(3):732-742
pubmed: 33657223
PLoS One. 2021 Feb 24;16(2):e0246513
pubmed: 33626045
BMC Public Health. 2004 Jun 03;4:19
pubmed: 15176983

Auteurs

Gabriele Pagani (G)

Malattie Infettive, Ospedale Nuovo di Legnano, ASST Ovest Milanese, 20025 Legnano, Italy.

Federico Conti (F)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.
Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Andrea Giacomelli (A)

Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Letizia Oreni (L)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.

Martina Beltrami (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.
Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Laura Pezzati (L)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.
Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Giacomo Casalini (G)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.
Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Rossana Rondanin (R)

Medispa S.r.l., 20122 Milan, Italy.

Andrea Prina (A)

Medispa S.r.l., 20122 Milan, Italy.

Antonino Zagari (A)

Direzione Socio-Sanitaria, ASST FBF-Sacco, 20157 Milan, Italy.

Stefano Rusconi (S)

Malattie Infettive, Ospedale Nuovo di Legnano, ASST Ovest Milanese, 20025 Legnano, Italy.
Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.

Massimo Galli (M)

Dipartimento di Scienze Biomediche e Cliniche "L. Sacco", Università degli Studi di Milano, 20157 Milan, Italy.
Malattie Infettive III Divisione, ASST FBF-Sacco, 20157 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH